According to the research report titled ‘Global Sacroiliac Joint Fusion Market Size study, By Indication (Degenerative Sacrolitiis, Sacral Disruption, Trauma), By Surgery (MIS, Open), By Product (Implants, Accessories), By End User (Hospitals, Ambulatory Surgical Centers, Others (Specialty Centers, Research & Academic Institutes)) and Regional Forecasts 2021-2027’, available with the MarketStudyReport, global sacroiliac joint fusion market is expected to reach USD 579.8 billion by 2027 from USD 187.5 billion in 2020, registering a CAGR of 17.5% during the study period.
 

The expanding elderly population and the rising prevalence of various injuries are the major driving factors for the growth of global sacroiliac joint fusion market over the projection period. Additionally, the adoption of this product is likely to increase further primarily due to growing government investment for improving the public healthcare infrastructure.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4566283/
 

For those unaware, sacroiliac joint fusion is a minimally invasive procedure that requires only a small incision and is known to have numerous applications in hospitals as well as ambulatory surgical centers.
 

Thus, shifting preferences towards minimally invasive procedures is stimulating the overall industry outlook. On the contrary, lack of awareness is likely to limit the market growth over the projection period.
 

By indication, worldwide sacroiliac joint fusion industry is segmented into trauma, sacral disruption, degenerative sacroiliitis. In terms of the surgery, the market is classified into open and MIS segments.
 

Based on product landscape, the industry is divided into accessories and implants segments. By end-user reach, the market is divided into surgical centers, hospitals, specialty centers, research centers, and others.
 

From the regional point of view, global sacroiliac joint fusion market is bifurcated into Latin America (Mexico, Brazil), Europe (Spain, Germany, the U.K, Italy), North America (the U.S, Canada), Asia-Pacific (India, South Korea, China, Japan, Australia), and rest of the world.
 

According to the report, North America sacroiliac joint fusion industry is anticipated to register considerable growth during the forecast period, owing to availability of favorable reimbursement coverage. Improving in the healthcare infrastructure, technological innovations, and rise in government investments towards medical sectors are also facilitating the business outlook in North America.
 

Medtronic plc, Surgalign Holdings Inc., Xtant Medical Holdings, CoreLink LLC, Camber Spine Technologies LLC, Life Spine Inc., Orthofix Medical Inc., Globus Medical & General Stores, SIGNUS Medizintechnik GmbH, and SI-BONE Inc. are the major companies operating in global sacroiliac joint fusion industry.